MAML1 Enhances the Transcriptional Activity of Runx2 and Plays a Role in Bone Development by Watanabe, Takashi et al.
MAML1 Enhances the Transcriptional Activity of Runx2
and Plays a Role in Bone Development
Takashi Watanabe1,2, Toshinao Oyama3, Maki Asada1, Daisuke Harada1, Yoshiaki Ito1,2,
Masayo Inagawa1, Yutaka Suzuki4, Sumio Sugano4, Ken-ichi Katsube5, Gerard Karsenty6,
Toshihisa Komori7, Motoo Kitagawa3, Hiroshi Asahara1,2,8*
1Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, Japan, 2Department of Systems Biomedicine, Tokyo Medical
and Dental University, Tokyo, Japan, 3Department of Molecular and Tumor Pathology, Chiba University Graduate School of Medicine, Chiba, Japan, 4Department of
Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan, 5Department of Oral Pathology, Graduate School of Medical and
Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 6Department of Genetics and Development, Columbia University, New York, New York, United States
of America, 7Department of Cell Biology, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan, 8Department of Molecular and Experimental
Medicine, The Scripps Research Institute, La Jolla, California, United States of America
Abstract
Mastermind-like 1 (MAML1) is a transcriptional co-activator in the Notch signaling pathway. Recently, however, several
reports revealed novel and unique roles for MAML1 that are independent of the Notch signaling pathway. We found that
MAML1 enhances the transcriptional activity of runt-related transcription factor 2 (Runx2), a transcription factor essential for
osteoblastic differentiation and chondrocyte proliferation and maturation. MAML1 significantly enhanced the Runx2-
mediated transcription of the p6OSE2-Luc reporter, in which luciferase expression was controlled by six copies of the
osteoblast specific element 2 (OSE2) from the Runx2-regulated osteocalcin gene promoter. Interestingly, a deletion mutant
of MAML1 lacking the N-terminal Notch-binding domain also enhanced Runx2-mediated transcription. Moreover, inhibition
of Notch signaling did not affect the action of MAML1 on Runx2, suggesting that the activation of Runx2 by MAML1 may be
caused in a Notch-independent manner. Overexpression of MAML1 transiently enhanced the Runx2-mediated expression of
alkaline phosphatase, an early marker of osteoblast differentiation, in the murine pluripotent mesenchymal cell line
C3H10T1/2. MAML12/2 embryos at embryonic day 16.5 (E16.5) had shorter bone lengths than wild-type embryos. The area
of primary spongiosa of the femoral diaphysis was narrowed. At E14.5, extended zone of collagen type II alpha 1 (Col2a1)
and Sox9 expression, markers of chondrocyte differentiation, and decreased zone of collagen type X alpha 1 (Col10a1)
expression, a marker of hypertrophic chondrocyte, were observed. These observations suggest that chondrocyte maturation
was impaired in MAML12/2 mice. MAML1 enhances the transcriptional activity of Runx2 and plays a role in bone
development.
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Introduction
Runt-related transcription factor 2 (Runx2) is a transcription
factor belonging to the Runx gene family, which is homologous to
Drosophila runt, a pair-rule gene involved in somitogenesis [1].
Runx2 is an essential factor for bone and hypertrophic cartilage
formation that is expressed very early in bone development and
continues to be present through the later phase of development
[2]. Runx2 promotes the differentiation of pluripotent mesenchy-
mal progenitor cells into the osteogenic lineage, but its role in
terminal differentiation to mature osteoblasts and the production
of bone matrix remains unclear. To date, it has been reported that
several transcription factors and cofactors, such as TAZ [3], Grg5
[4], Rb [5], and HDAC4 [6], interact with Runx2 and positively
or negatively regulate its function. However, in many cases, the
physiological significance of the interaction is unclear. To further
elucidate the function of Runx2, we performed luciferase assay-
based screening of additional factors regulating the transcriptional
activity of Runx2 using a full-length cDNA library containing
approximately 10,000 clones. The screening system identified the
mastermind-like (MAML) family of proteins showed especially
strong potential for regulating Runx2 transcriptional activity.
Overexpression of MAML1 enhanced the Runx2-mediated
expression of alkaline phosphatase, an early marker of osteoblast
differentiation, in C3H10T1/2 cells. Furthermore, MAML12/2
embryos at E14.5 and 16.5 had shorter bone lengths than wild
type embryos. The area of primary spongiosa of the femoral
diaphysis was narrowed, indicated that chondrocyte maturation
was impaired. These data suggest that MAML1 enhanced the
transcriptional activity of Runx2 and plays a role in bone
development.
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Results
MAML1 enhances the transcriptional activity of Runx2
We used a full-length cDNA library containing approximately
10,000 clones (FLJ clones, established by New Energy and
Industrial Technology Development Organization [NEDO],
Japan) and p6OSE2-Luc reporter assay system (Figure 1A). We
identified a few novel factors that enhance Runx2 transcriptional
activity. Among them, AK123604 (Homo sapiens cDNA FLJ41610),
which is highly similar to Mastermind-like protein 3 (MAML3),
showed especially strong activity. MAML is a human homolog of
Drosophila mastermind, a protein that plays a role in the Notch
signaling. MAML family members consist of MAML1, MAML2
and MAML3. We found that MAML1 and MAML2 also
enhanced Runx2 transcriptional activity as well (Figure 1B).
Because the establishment of knockout mice of MAML1 preceded
MAML2 and MAML3, we primarily analyzed MAML1.
MAML1 enhances Runx2 activity in a Notch-independent
manner in vitro
MAML1 consists of 1016 amino acids and contains a conserved
basic region and two acidic regions. To investigate which region is
essential for regulating Runx2, we assessed each deletion mutant
by p6OSE2-Luc reporter assay (Figure 2). The N-terminal basic
region, which is essential for the interaction with Notch, and the
C-terminal acidic region of MAML1 were dispensable for Runx2
transcriptional activity. On the other hand, the center region
(residues 343–711), whose function is not well known, was
essential.
Because MAML1 is a coactivator of Notch signaling, we
investigated whether or not the action of MAML1 on Runx2 was
dependent on Notch. Notch1DE is cleaved by c-secretase to
produce the Notch intracellular domain (NICD), which translo-
cates into the nucleus and transactivates the target
gene. A C-secretase inhibitor DAPT inhibited the
Notch1DE-mediated activation of pTP1-Luc, in which luciferase
expression was controlled by Notch signaling (Figure 2C). On the
other hand, DAPT did not affect the action of MAML1 on Runx2
in the presence of Notch1DE (Figure 2D). This suggests that
MAML1 possibly enhance the transcriptional activity of Runx2 in
a Notch-independent manner.
MAML1 promotes Runx2-mediated osteoblastic
differentiation
293T cell used in the luciferase assay is derived from human
embryonic kidney and does not express Runx2. Therefore, we
next investigated whether MAML1 controls osteoblastic differen-
tiation through Runx2 in the murine pluripotent mesenchymal cell
line C3H10T1/2 (Figure 3). Overexpression of Runx2 promoted
the expression of the ALP gene, an early osteoblast marker. Co-
overexpression of MAML1 rapidly augmented the Runx2-
mediated expression of ALP, whereas MAML1 alone did not
induce ALP expression. However, this effect was observed only in
Figure 1. MAML1 enhances the transcriptional activity of Runx2. A, 293T cells were transiently transfected with p6OSE2-Luc reporter, Runx2
expression plasmid, and about 10,000 FLJ expression plasmids. B, 293T cells were transiently transfected with a p6OSE2-Luc reporter or p6OSE2-
mutant-Luc together with MAML1, MAML2, MAML3, and Runx2 expression plasmids. Luciferase levels were normalized to the Renilla luciferase
activity of a cotransfected phRL-TK-Luc reporter and presented as fold activation relative to the luciferase level of the p6OSE2-Luc reporter construct
alone. Error bars represent the standard deviation of triplicate transfections.
doi:10.1371/journal.pgen.1003132.g001
Author Summary
To identify new molecules involved in bone and cartilage
development and/or homeostasis, we utilized approxi-
mately 10,000 arrayed and addressable cDNA clones,
which allowed systematic, efficient, and unbiased screen-
ing of cDNAs encoding factors that could activate critical
bone differentiation activity via activation of Runx2, master
regulator of bone development. We analyzed MAML12/2
mice to investigate the role of MAML1 in bone develop-
ment. MAML12/2 embryos at embryonic day 14.5 and 16.5
had shorter bone lengths than wild-type embryos. The
area of primary spongiosa of the femoral diaphysis was
narrowed, indicated that chondrocyte maturation was
impaired. This revealed that MAML1 plays an important
role in proper bone development and may provide us with
a new basis for identifying potential therapeutic targets for
bone diseases.
MAML1 Enhances Runx2 Transcriptional Activity
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early phase of osteoblast differentiation and later phase markers
such as bone sialoprotein and osteocalcin were not changed (data
not shown).
Analysis of skeletal defects in MAML12/2 mice
We analyzed MAML1 knockout (MAML12/2) mice [7].
Normal Mendelian ratios are observed up to E18.5, but
MAML12/2 mice with C57BL/6 background die during the
perinatal period. In the original paper, however, MAML12/2
mice die within 14 days after birth [7]. The difference of lethality
in the mice is thought to be due to the difference of the
background. At E16.5, MAML12/2 mice were smaller than wild
type mice (Figure 4A). Whole mounted embryos at E16.5 stained
with Alcian Blue and Alizarin Red showed that the mineralized
region in the long bones of MAML12/2 mice was relatively short
compared with wild type mice (Figure 4A). Histological analysis
revealed that the area of primary spongiosa of the femoral
diaphysis was reduced in MAML12/2 mice compared to wild
type mice (Figure 4B, 4C). At E14.5, extended zone of Col2a1 and
Sox9 expression, markers of chondrocyte differentiation, and
decreased zone of Col10a1 expression, a marker of hypertrophic
chondrocyte, were observed (Figure 4D). These observations
indicated the impairment of chondrocyte maturation in
MAML12/2 mice.
Discussion
We utilized approximately 10,000 arrayed and addressable
cDNA clones, which allowed systematic, efficient, and unbiased
screening of cDNAs encoding factors that could activate
Figure 2. MAML1 enhances Runx2 activity in a Notch-independent manner in vitro. A, The structure of MAML1 and its truncated forms. B,
293T cells were transiently transfected with a p6OSE2-Luc reporter alone or together with truncated forms of MAML1 Error bars represent the
standard deviation of triplicate transfections. C, 293T cells were transiently transfected with a pTP1-Luc reporter and NotchDE expression plasmid in
the presence of c-secretase inhibitor (DAPT). Error bars represent the standard deviation of triplicate transfections. D, 293T cells were transiently
transfected with a p6OSE2-Luc reporter with Runx2, MAML1 and NotchDE expression plasmid in the presence of c-secretase inhibitor (DAPT). Error
bars represent the standard deviation of triplicate transfections.
doi:10.1371/journal.pgen.1003132.g002
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Runx2-mediated expression of the p6OSE2-Luc reporter con-
struct (Figure 1). This revealed that MAML was a potential
activator of Runx2-mediated luciferase expression.
MAML is a coactivator of Notch signaling. Upon ligand
stimulation from neighboring cells, Notch is cleaved by c-secretase
and its intracellular domain (NICD) translocates into the nucleus
[8]. NICD interacts with CSL through a RAM domain at the N-
terminus that has high affinity for the b-trefoil domain of CSL.
Then, the ankyrin repeats domain of NICD docks with the Rel-
homology domain of CSL and creates a high-affinity binding site
for MAML. MAML associates with the CSL-NICD complex
through the N-terminal basic region, recruits p300, RNA
polymerase II and other unknown factors, and activates the
transcription of target genes such as Hes1 [9,10]. On the other
hand, Notch-independent action of MAML1 on p53 [11], beta-
catenin [12], MEF2C [13] and NF-kappaB [14] has been
previously reported.
Recently, two groups have published studies using genetically
modified mice [15,16]. Hilton and colleagues showed that Notch
signaling inhibits osteoblast differentiation through Hes or Hey
proteins, which diminish Runx2 transcriptional activity via
physical interaction, and acts to maintain a pool of mesenchymal
progenitors. Engin and colleagues showed that pathological gain of
Notch function in established osteoblastic lineages activates
expansion of the immature osteoblastic pool by increasing
transcription of the genes encoding osterix, cyclin D and cyclin
E and by repressing the function of Runx2 by direct interaction
and inhibition of its binding. These findings suggest that Notch
signaling negatively regulate the function of Runx2. We indicated
that the N-terminal Notch-binding region of MAML1 is dispens-
able for the action of MAML1 on Runx2 and Notch signaling
inhibitor does not affected the action of MAML1 on Runx2.
Furthermore, knockdown of p300, a coactivator [9,10], did not
affected the activation of Runx2 transcriptional activity by
MAML1 (data not shown). These data suppose that the action
of MAML1 on Runx2 is Notch-independent.
To elucidate how MAML regulates Runx2-mediated transcrip-
tion, we investigated the physical interaction of MAML1 with
Runx2, but we could not demonstrate the interaction between
Runx2 and MAML1 (data not shown), suggesting that this
interaction is very weak and possibly indirect.
We showed the impairment of chondrocyte maturation in
MAML12/2 mice. Because Runx2 facilitates chondrocyte matu-
ration, the phenotype of MAML12/2 mice may be caused by the
dysfunction of Runx2. On the other hand, the expression of Sox9,
a transcription activator of collagen type II, was upregulated by
Notch activation and this activation of Notch signaling thereby
promoted differentiation of proliferative and prehypertrophic
chondrocytes [17]. Therefore, from this current findings, it is
not clear yet whether or not the phenotype of MAML12/2 mice is
due to the dysfunction of Runx2 or Notch signaling. Other
possibility to explain MAML12/2 mice bone phenotype is that
other cell signaling cascades and molecules could be involved into
MAML dependent gene regulation and thus bone development.
Figure 3. MAML1 promotes Runx2-mediated osteoblastic differentiation. A, C3H10T1/2 cells were transiently transfected with a Runx2 and/
or MAML1 expression plasmids and cultured for 2 days. B, Total RNA was isolated and reverse-transcribed and TaqMan real-time PCR was performed
to investigate the expression level of alkaline phosphatase gene, a marker of osteoblast.
doi:10.1371/journal.pgen.1003132.g003
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For example, MEF2C, a transcription factor that regulates muscle
and cardiovascular development, was reported to control bone
development by activating the gene program for chondrocyte
hypertrophy [18].
Taken together, our analysis revealed novel function of
MAML1, Notch independent promotion of Runx2 activity and
its role in bone development. Further elucidation of the precise
molecular mechanisms responsible for the initiation and termina-
tion of this functional association during bone development may
provide us with a new basis for understanding the molecular




All animal experiments were performed according to protocols
approved by the Institutional Animal Care and Use Committee at
National Institute for Child Health and Development (Protocol
2004-003).
Figure 4. Analysis of skeletal defects in MAML12/2mice. A, Whole mounted embryos at E16.5 were stained with Alcian Blue and Alizarin Red.
B, The femoral sections at E16.5 were stained with Alcian Blue (upper panel). Arrow bar indicates the area of primary spongiosa. The expression of
collagen, type 10 alpha 1, a marker of hypertrophic chondrocyte, was shown by in situ hybridization (lower panel). Green bars, primary spongiosa; red
bars, hypertrophic zone; blue bars, proliferating zone. Black bars, 200 mm. C, The primary spongiosa length of MAML1 null (KO) embryos and wild
type (WT) littermates. D. Femoral sections at E14.5. The expression of type 10 alpha 1 collagen, type 2 alpha 1 collagen and sox9 was shown by in situ
hybridization. Bars, 100 mm.
doi:10.1371/journal.pgen.1003132.g004
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Plasmids
The p6OSE2-Luc and p6OSE2-mut-Luc reporter construct
were previously reported [19]. The pEF-BOS hMam-1 (MAML1)
plasmid, its truncated forms [20], hMam-2 (MAML3), hMam-3
(MAML2) [21] and pCS2+Notch1DE [22] were previously
reported. The pCG mRunx2 plasmid by Dr. Nakashima (Tokyo
Medical and Dental University, Tokyo), and the p3xFLAG
mRunx2 plasmid by Dr. Hikata (Keio University, Tokyo). The
pTP1-Luc (pGa981-6) construct was provided by Dr. Ursula
Strobl (Institute of Clinical Molecular Biology and Tumor
Genetics, Germany).
Reporter assays
For the primary screening, we diluted approximately 10,000
FLJ clones (Full-length human cDNA sequencing project, NEDO)
to 10 ng/mL in 10 mM Tris-HCl (pH 8.5), and dispensed 5 mL to
each well in 384-well plates. We then added 10 ng of p6OSE2-
Luc, 2 ng of pCG, 0.1 mL of Fugene6 (Roche Diagnostics), and
5 mL of Opti-MEM I Reduced-Serum Medium (Invitrogen) to
each well. 293T cells were diluted to 1.256105 cells/mL with
Dulbecco’s modified Eagle medium (DMEM) containing 10%
heat-inactivated fetal bovine serum (FBS), 50 units/mL penicillin,
and 50 mg/mL streptomycin, and seeded at 40 mL (5,000 cells) per
well. After 48 hours of culture, we removed the supernatant and
added 40 mL of Steady Glo Luciferase Assay Reagent (Promega)
diluted 2-fold with phosphate buffered saline (PBS) to each well.
After 10 minutes at room temperature, luminescence was mea-
sured using a plate reader (ARVO, Perkin Elmer). After the
second screening, the assay was performed in 96-well plates. We
added c-secretase inhibitor IX, N-[N-(3, 5-difluorophenylacetyl-L-
alanyl)]-S-phenylglycine t-butylester (DAPT; Calbiochem), to the
medium 2 hours before transfection.
Cell culture, transfection, and differentiation assays
We purchased the C3H10T1/2 murine pluripotent mesenchy-
mal cell line from ATCC and maintained it in DMEM containing
10% heat-inactivated FBS, 50 units/mL penicillin, and 50 mg/mL
streptomycin. For differentiation assays, we seeded cells in a multi-
well plate at a density of 2,000 cells/cm2 and cultured them for 3
days. The medium was then changed to the osteoblastic medium
(MEM-alpha containing heat-inactivated FBS, 50 units/mL
penicillin, 50 mg/mL streptomycin, 50 mM ascorbic acid 2-
phosphate, 10 mM b-glycerophosphate, and 0.1 mM dexametha-
sone), transfected with p3xFLAG-Runx2 and/or pEF BOS-
hMam1 by FugeneHD (Roche diagnostics), and cultured.
Real-time PCR
We isolated total RNA from the cultured cells using the RNeasy
mini kit (QIAGEN) and reverse transcribed 2 mg of total RNA
using Ready-To-Go You-Prime First-Strand Beads (GE Health-
care) and oligo-dT primer. The products were diluted 10-fold with
distilled water and used as a template for real-time PCR. Real-
time PCR was performed using a TaqMan Gene Expression
Assay, TaqMan Universal PCR Mix and the 7900HT Fast Real-
Time PCR System (Applied Biosystems).
Double staining of MAML12/2 mouse embryos
We backcrossed MAML1 null mice [7] at least 10 times onto a
C57BL/6 background. We fixed mouse embryos on embryonic
day 16.5 (E16.5) in ethanol overnight and then stained them
overnight with Alcian blue solution (0.15 mg/mL Alcian blue
8GX in 20% acetic acid and 80% ethanol). The embryos were
washed briefly with ethanol twice, treated with 2% potassium
hydroxide overnight, and then stained overnight with Alizarin red
solution (0.075 mg/mL Alizarin red S in 1% potassium hydrox-
ide).
Alcian blue staining
Tissues were fixed in 4% paraformaldehyde-PBS overnight at
4uC, processed, embedded in paraffin, and sectioned. Slides were
deparaffinized, washed with water, treated with 3% acetic acid,
and then with 1% Alcian blue 8GX for 60 minutes. After staining,
we washed the slides briefly with 3% acetic acid, then with water
for 5 minutes, counterstained with Kernechtrot Stain Solution
(Muto Pure Chemicals, Tokyo) for 5 minutes, washed with water
for 3 minutes, and dehydrated the slides.
In situ hybridization
Tissues were fixed in 4% paraformaldehyde-PBS overnight at
4uC, processed, embedded in paraffin, and sectioned. Slides were
deparaffinized, treated with proteinase K (8 mg/mL) for 10 min-
utes at RT, and then with 0.2% glycine in PBS for 10 minutes at
RT. Slides were refixed in 4% paraformaldehyde-PBS for
10 minutes at RT, washed with PBS for 5 minutes 3 times,
acetylated with 0.1 M triethanolamin-HCl (pH 8.0) for 10 min-
utes, washed with PBS for 30 minutes, and then prehybridized
with prehybridization buffer (50% deionized formamide and 56
saline-sodium citrate (SSC)) for 60 minutes at 65uC. We hybrid-
ized the slides with DIG-labeled antisense riboprobes in hybrid-
ization buffer (50% deionized formamide, 56 SSC, 0.25 mg/mL
yeast tRNA, 10% dextran sulfate, and 56Denhardt’s solution) in
a humidified chamber at 65uC overnight. After hybridization, the
slides were washed with 56SSC (16SSC: 0.15 M NaCl, 0.015 M
sodium citrate) at 65uC for 20 minutes, 0.26 SSC at 65uC for
3 hours, and NT buffer (0.1 M Tris-HCl [pH 7.5], 0.15 M NaCl)
for 5 minutes at RT. We incubated the slides at 4uC overnight
with alkaline phosphatase (ALP)-coupled anti-DIG antibody in
NT buffer containing 0.1% sheep serum. The slides were washed
with NT buffer for 15 minutes 3 times and equilibrated in NTM
(0.1 M NaCl, 0.1 M Tris-HCl [pH 9.5], and 0.05 M MgCl2) for
5 minutes at RT. The slides were then treated with BM Purple AP
Substrate (Roche) for 3 hours at RT in a humid chamber
protected from light.
Statistical analysis
The two-tailed independent Student’s t-test was used to
calculate all P values.
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